| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Annexin A9 Blocking Peptide is synthetically produced from the 1-100 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | ANXA9 |
| Gene ID: | 8416 |
| Uniprot ID: | ANXA9_HUMAN |
| Immunogen Region: | 1-100 |
| Immunogen: | Synthetic peptide taken within amino acid region 1-100 on human Annexin A9 protein. |
| Tissue Specificity | Expressed in the stratified squamous skin epithelium, but not in epithelia of other types (at protein level). |
| Function | Low affinity receptor for acetylcholine known to be targeted by disease-causing pemphigus vulgaris antibodies in keratinocytes. |
| Peptide Name | Annexin A9 Annexin Xxxi Annexin-31 Annexin-9 Pemphaxin |
| Alternative Peptide Names | Annexin A9 protein Annexin Xxxi protein Annexin-31 protein Annexin-9 protein Pemphaxin protein ANXA9 protein ANX31 protein |
Information sourced from Uniprot.org